Key Details
Price
$0.41Annual ROE
-921.57%Beta
-1.60Events Calendar
Next earnings date:
May 20, 2025Recent quarterly earnings:
Aug 07, 2024Recent annual earnings:
Mar 09, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Oct 19, 2023Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Shares of NexImmune (NASDAQ: NEXI ) stock are skyrocketing higher ahead of the company's special meeting of stockholders. The meeting was initially set for Dec. 21 with a record date of Nov. 6.
Inexplicably, shares of embattled immunotherapy specialist NexImmune (NASDAQ: NEXI ) are skyrocketing more than 190% despite efforts to dissolve the business. An earlier attempt to vote on the liquidation and dissolution of the biotechnology enterprise failed due to a lack of quorum.
Following a dramatic spike in shares yesterday, exchange operators at Nasdaq pulled the circuit breaker on NexImmune (NASDAQ: NEXI ). Though seemingly offering innovative solutions to disease treatment, the biotechnology firm has lost almost all its value since its initial public offering in 2021.
NexImmune (NASDAQ: NEXI ) stock is heading higher on Friday despite a lack of news from the clinical-stage biotechnology company. There are no new press releases for filings with the Securities and Exchange Commission (SEC) that help explain why NEXI stock is up today.
FAQ
- What is the primary business of NexImmune?
- What is the ticker symbol for NexImmune?
- Does NexImmune pay dividends?
- What sector is NexImmune in?
- What industry is NexImmune in?
- What country is NexImmune based in?
- When did NexImmune go public?
- Is NexImmune in the S&P 500?
- Is NexImmune in the NASDAQ 100?
- Is NexImmune in the Dow Jones?
- When was NexImmune's last earnings report?
- When does NexImmune report earnings?
- Should I buy NexImmune stock now?